🇺🇸 FDA

Drug profile · INN

erythromycin

ILOTYCIN

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

erythromycin (ILOTYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN erythromycin
Brand ILOTYCIN
Route OPHTHALMIC
Formulation TABLET
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12370255

    Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12365659

    Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12343424

    Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12311054

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12264366

    Genome-based methods for reducing cardiovascular risk

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12233103

    Indoleamine 2,3-dioxygenase based immunotherapy

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12144877

    Graphene-based multifunctional cosmetic compositions

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12133884

    Methods of substituting pathogenic amino acids using programmable base editor systems

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is erythromycin?

erythromycin (ILOTYCIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for erythromycin?

ILOTYCIN is a marketed brand name for erythromycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of erythromycin?

erythromycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.